Cataract

Advances in intraoperative aberrometry are increasing the likelihood that, in the near future, ophthalmologists will be able to achieve emmetropia for all patients undergoing cataract surgery.

Cataract surgery performed with intraoperative wavefront aberrometry while implanting a new aspheric hydrophobic acrylic IOL maximizes visual acuity and quality-of-vision results.

An injectable intraocular sustained release drug delivery system demonstrated favorable safety and efficacy results in a multicenter phase II clinical trial.

Immediately sequential bilateral cataract surgery may be in peril as a procedure because it is penalized to varying degrees by government-imposed reimbursement cuts.

James A. Davison, MD, describes the features and performance of a new phacoemulsification system (Centurion Vision System, Alcon Laboratories).

Use of a Kelman non-flared phaco tip-when performing torsional phacoemulsification in eyes with dense cataracts-will minimize prolonged occlusion episodes, show study results.

Multipoint scleral suture fixation through the fibrotic rim of a continuous curvilinear capsulorhexis results in stable recentration of a dislocated IOL-capsular bag complex

The in situ fracture – thin bowl technique is designed to reduce the risk of corneal endothelial damage when removing hard cataracts. Clinical study data show that it works.

A one-handed IOL insertion device allows for smoother, less traumatic lens insertions even in difficult incisions and eyes.

One ophthalmologist proposes a practice-changing opportunity to eliminate the use of eye drops after cataract surgery.

The concept of vision à la carte allows all ophthalmic surgeons to design vision for each patient individually, using all of today’s technologies and techniques.

Sometimes, it is hard to prove what you know to be true is actually true. So, it’s nice to know there is a paper confirming something I have also known to be true: People who lose visual acuity as a result of cataracts will-if they have cataract surgery to restore their vision-live longer than those who do not have surgery.

There are several vital components surgeons need to take into consideration when treating children who have traumatic cataracts.

Cataract surgery not only can result in a reduction of IOP, it also provides benefits for future management of glaucoma.

There are numerous methods and factors surgeons should examine for patients with age-related macular degeneration and who require cataract surgery to avoid future problems.

The financial feasibility of using only one laser for all procedures is a given. Arun C. Gulani, MD, takes this one step further, arguing that perhaps the future may hold cases in which use of the femtosecond laser is a necessity, becoming a standard-of-care concept.

While manual limbal relaxing incisions and femtosecond femtosecond astigmatic keratotomies can address mild to moderate astigmatism, toric IOLs are quite effective at all ranges of astigmatism, relates one surgeon.

A single-piece hydrophobic acrylic IOL has many features that make it a good choice for a monofocal implant in routine and challenging cataract surgery cases.

Postoperative hypotony is a problem not often seen by ophthalmologists, but when it occurs, elucidating its exact cause and treating it properly is imperative.

Using the strengths of both peristaltic and venturi phaco, a modified chop technique increases efficiency and safety in denser nuclei.

A new non-flared Kelman bent tip for torsional ultrasound phacoemulsification retains the same high-cutting efficiency of the mini-flared Kelman tip but without the latter’s propensity for inadvertent prolonged occlusion.

Outcomes from use of a proprietary femtosecond laser system (Catalys Precision Laser System, OptiMedica) to perform cataract surgery in a series of 850 eyes, of which 25% have some comorbidity, are testament to its reliability and safety.

Findings point to improvements in cleaning procedures, less reuse of cannulas

Higher-concentration drug statistically superior to vehicle for achieving resolution of inflammation

Phase IIb, III data show anti-inflammatory/mydriatic agent reduces miosis

Study shows better reproducibility with devices dedicated to standardizing capsulorhexis

The FDA has approved Bausch + Lomb’s Trulign lens, a toric posterior chamber IOL that corrects for astigmatism and has the capacity to deliver improved vision across a natural range of focus.

Survey results paint portrait of trends, technology’s effect on cataract practice

Lens demonstrated excellent rotational stability, visual outcomes in clinical trials